Tags: Obinutuzumab
Highlights in Chronic Lymphocytic Leukemia From the 2020 American Society of Clinical Oncology Annual Meeting
May 29-31, 2020 • Virtual Venetoclax/Obinutuzumab Continues to Demonstrate Superior Efficacy Long-term results from the CLL14 trial continue to show that fixed-duration venetoclax/obinutuzumab (VenG) continues […]
CLL in Focus
Watch and Wait Remains Best Approach for High-Risk Binet Stage A Chronic Lymphocytic Leukemia The current standard of care for patients with Binet stage A chronic […]